| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |